SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending strongly following a KeyBanc upgrade, positive reports on its 18A and 14A foundry progress with potential major client wins like Apple, and significant public endorsement from the US government highlighting domestic chip manufacturing. The community is buzzing about Intel's potential return to technological leadership and its role as a "National Champion" amid broader geopolitical shifts, with many anticipating substantial long-term growth driven by these strategic foundry advancements and government backing.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending with strong community anticipation for its pivotal role in next-generation AI data centers, leveraging advanced GaN and SiC power solutions for architectures like NVIDIA's 800V AI factory. This foundational technology, coupled with substantial short interest, is fueling speculation of a significant short squeeze and potential breakout, especially ahead of upcoming industry conference appearances.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after receiving positive FDA feedback, significantly de-risking the regulatory path for its lead asset, sonelokimab, in hidradenitis suppurativa. This news has ignited intense community speculation around a potential acquisition by major pharmaceutical companies, including Merck and Eli Lilly, as investors keenly eye its "best-in-class" potential and upcoming industry events. The market is actively re-evaluating MLTX's value, with many anticipating substantial upside.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings (ANPA) is trending due to its recent acquisition of TikTok icon Khaby Lame's core company and a private placement. This has ignited massive speculative interest and a fervent short squeeze narrative, with many community members predicting significant upward movement, while others caution about its low-float nature and potential for rapid reversals, drawing comparisons to other volatile Hong Kong IPOs.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following its confirmed partnership with Google to integrate Gemini AI into Siri, a development many in the community view as addressing prior concerns about its artificial intelligence strategy without incurring significant R&D expenses. This catalyst, coupled with recent reports highlighting strong iPhone market share and anticipation of upcoming earnings, is fueling broad discussions about the company's future trajectory after a period of price fluctuations.

Monero

Monero (XMR) is trending amidst a renewed and intense community discussion around the critical importance of privacy in the crypto space, with many hailing it as the "real Bitcoin." The immediate catalyst appears to be its recent price momentum and ongoing debate over privacy-focused assets, especially as users emphasize its resilience against institutional influence and delistings. The community is actively discussing Monero's fundamental utility as a truly private and censorship-resistant digital currency.

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Travere Therapeutics Inc

Travere Therapeutics is trending following news that the FDA requested additional information to characterize the clinical benefit of FILSPARI for its Focal Segmental Glomerulosclerosis (FSGS) approval, triggering a significant market sell-off. The community is sharply divided, with many anticipating a Complete Response Letter (CRL) and noting recent insider selling as a red flag, while others view the dramatic dip as an overreaction, highlighting FILSPARI's existing success and the high unmet medical need in FSGS.

Portillo's, Inc. serves street food through high-energy, multichannel restaurants designed to ignite the senses and create a memorable dining experience. The company was founded on June 8, 2021 and is headquartered in Oak Brook, IL.

Portillos Inc - Ordinary Shares - Class A

Portillo's is trending due to the undeniable success of its new Kennesaw, GA location, which is driving significant sales and validating the brand's expansion potential outside its home market. The community is actively debating the company's deep undervaluation and high short interest, fueled by anticipation of a new CEO announcement and potential relief from fluctuating beef prices.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, Ketjen, and All Other. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The All Other segment refers only to the FCS business that did not fit into any of the company’s core businesses. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Albemarle is experiencing a powerful surge driven by a significant rebound in lithium prices and heightened demand from the EV and energy storage sectors. Recent analyst upgrades and speculation about potential government backing for domestic critical mineral producers amid evolving trade policies are fueling widespread bullish sentiment and discussions about a major market 'regime shift'.

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Alumis Inc.

Alumis (ALMS) is trending following highly positive Phase 3 clinical trial results for its oral psoriasis therapy, envudeucitinib, which showed strong skin clearance and a favorable safety profile. The community is actively discussing the drug's "best-in-class" potential, fueling speculation about a significant valuation increase and a potential buyout, with analysts raising price targets. This bullish sentiment persists despite the company's recent announcement of a proposed public offering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
